Semaglutide: all 426 studies that test it

Page 2 of 5. Open to participants first (151), then studies with results posted, then the rest; newest registration first within each.

• GLP-1R Agonist Treatment for Opioid Use DisorderRecruitingNCT06548490Phase 2
• GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver DiseaseNot yet recruitingNCT06546384Not applicable
• Mechanisms of Semaglutide Therapy in Heart Failure PatientsRecruitingNCT06541509Phase 1/2
• Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial FibrillationRecruitingNCT06499857Phase 3
• The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic NeuropathyRecruitingNCT06461377Phase 4
• Semaglutide in Auto-HSCTNot yet recruitingNCT06449625Phase 2
• Prevention of Progression of Prediabetes, Obesity and CV RiskRecruitingNCT06446531Phase 1
• Effect of Weight Loss on Physical and Cardiac Performance in People With Obesity and Heart FailureRecruitingNCT06423599Phase 2/3
• Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity TreatmentRecruitingNCT06411210Phase 2
• Obesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2RecruitingNCT06396416Phase 4
• Exploratory Study on the Efficacy and Safety of Semaglutide for Idiopathic Intracranial Hypertension TreatmentNot yet recruitingNCT06361823Phase 3
• Efficacy and Safety of Semaglutide Injection in Subjects With Type 2 DiabetesNot yet recruitingNCT06339086Phase 3
• GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving TeplizumabRecruitingNCT06338553Early Phase 1
• The GAPSID Study - How GLP-1 Analogues Prevent Steroid-Induced DiabetesRecruitingNCT06318442Not applicable
• Semaglutide 2.4mg for Low Responders After Bariatric SurgeryNot yet recruitingNCT06287307Phase 4
• The Effect of Semaglutide on Disordered Eating Behaviour in Type 2 Diabetic PatientsNot yet recruitingNCT06243536Phase 4
• Semaglutide for Post-Smoking Cessation Weight ManagementRecruitingNCT06173778Phase 2
• Subcutaneous Semaglutide in Systemic SclerodermaRecruitingNCT06149260Phase 1
• Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 DiabetesRecruitingNCT06082063Phase 3
• Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Low-grade Cancer of the EndometriumRecruitingNCT06073184Phase 2
• COMMETS- Combination MCI Metabolic SyndromeRecruitingNCT06072963Phase 2
• The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic EffectRecruitingNCT06058585Phase 3
• Semaglutide GLP1 Agonists With Degludec Basal-bolus Insulin in Early Type 1 Diabetes to Basal-bolusNot yet recruitingNCT06057077Phase 1/2
• GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGHRecruitingNCT06003153Phase 4
• Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 DiabetesNot yet recruitingNCT05950516Phase 3
• The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant RecipientsRecruitingNCT05938712Phase 2
• Semaglutide and Vascular RegenerationRecruitingNCT05870462Phase 4
• Trial of Semaglutide for Diabetic Kidney Disease in Type 1 DiabetesRecruitingNCT05822609Phase 2
• Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary SyndromeRecruitingNCT05819853Phase 3
• Type 1 Diabetes Impacts of Semaglutide on Cardiovascular OutcomesRecruitingNCT05819138Phase 3
• Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 DiabetesRecruitingNCT05780905Phase 4
• Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes MellitusRecruitingNCT05779644Not applicable
• Feasibility of Semaglutide in Advanced Lung DiseaseRecruitingNCT05746039Phase 1/2
• Semaglutide Treatment for Hyperglycaemia After Renal TransplantationRecruitingNCT05702931Phase 4
• Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary SyndromeRecruitingNCT05702905Phase 4
• Semaglutide vs Metformin in Polycystic Ovary Syndrome (PCOS)Not yet recruitingNCT05646199Phase 2/3
• Acute Subcutaneous SemaglutidE in Acute Ischemic sTrokeRecruitingNCT05630586Phase 2
• Does the Hematopoietic Stem Cell Govern Residual Inflammatory Cardiovascular Risk in Type 2 DiabetesRecruitingNCT05597202Phase 4
• Sex Steroids Balance for Metabolic and Reproductive Health in Klinefelter SyndromeRecruitingNCT05586802Phase 3
• Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational DiabetesRecruitingNCT05569772Phase 3
• Adipose Tissue Heterogeneity and Its Link to Type 2 DiabetesRecruitingNCT05501483Not applicable
• Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver TransplantRecruitingNCT05424003Phase 2
• Genetics of the Acute Response to Oral SemaglutideRecruitingNCT05340868Not applicable
• Sit Less, Interact and Move More (SLIMM) 2 StudyRecruitingNCT05173714Phase 2
• Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With PrediabetesRecruitingNCT05119179Phase 4
• Pharmacogenetics of Response to GLP1R AgonistsRecruitingNCT05071898Phase 1
• Effect Of Semaglutide In Coronary Atheroma PlaqueNot yet recruitingNCT05071417Phase 3
• Treatment to Regress to Normoglycemia in Women with a Recent History of GDMRecruitingNCT04873050Phase 4
• Semaglutide as an Adjunct to Dieting in the Treatment of Type 2 DiabetesRecruitingNCT04854083Phase 4
• Semaglutide's Efficacy in Achieving Weight Loss for Those With HIVRecruitingNCT04174755Not applicable
• Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)RecruitingNCT03884075Phase 2
• A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight RangeCompletedNCT06041217Phase 3Results posted
• A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's DiseaseCompletedNCT05891496Phase 3Results posted
• A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 DiabetesCompletedNCT05813912Phase 3Results posted
• Semaglutide in CFRDCompletedNCT05788965Phase 2/3Results posted
• Effect of GLP1 Receptor Agonists on Physical Function, Body Composition, and Markers of Aging in Older AdultsCompletedNCT05786521Phase 4Results posted
• A Study to Evaluate the Effect of the Experimental GLP-1 Drug PF-07081532 on Blood Levels of Common Birth Control Pills, and Drugs Omeprazole and Midazolam, and Effect of GLP-1 Drug Semaglutide on Midazolam Blood Levels in Healthy Adults With Weight in the Obesity RangeTerminatedNCT05671653Phase 1Results posted
• A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose WeightCompletedNCT05649137Phase 3Results posted
• A Research Study to See How Semaglutide Helps People With Excess Weight, Lose Weight (STEP UP)CompletedNCT05646706Phase 3Results posted
• Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or ObeseCompletedNCT05616013Phase 2Results posted
• A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in AmericaCompletedNCT05579249Phase 4Results posted
• Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy RangeCompletedNCT05564117Phase 3Results posted
• Semaglutide Treatment, Appetite, and Eating Behavior: Long-term EffectsCompletedNCT05548647Phase 4Results posted
• ADJUnct Semaglutide Treatment in Type 1 DiabetesCompletedNCT05537233Phase 2Results posted
• Safety Study of Weekly Semaglutide in Chilean Participants With Type 2 DiabetesCompletedNCT05533632Phase 4Results posted
• Effects of Semaglutide on Nicotine IntakeCompletedNCT05530577Phase 2Results posted
• Semaglutide for Alcohol Use DisorderCompletedNCT05520775Phase 2Results posted
• A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)CompletedNCT05514535Phase 3Results posted
• A Research Study to Look Into How Well Semaglutide Medicine Works at Different Doses in People With Type 2 Diabetes and OverweightCompletedNCT05486065Phase 2Results posted
• A Research Study to Compare Two Semaglutide Medicines in People With Type 2 DiabetesCompletedNCT05478252Phase 3Results posted
• A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin IcodecCompletedNCT05352815Phase 3Results posted
• Semaglutide Use in Elderly Obese PatientsCompletedNCT05302596Phase 2Results posted
• A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)CompletedNCT05259033Phase 3Results posted
• A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 DiabetesCompletedNCT05144984Phase 2Results posted
• Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in East Asian People Who Are Overweight or Living With ObesityCompletedNCT05132088Phase 3Results posted
• Research Study Looking at How Well Semaglutide Works in People Suffering From Obesity and Knee OsteoarthritisCompletedNCT05064735Phase 3Results posted
• Research Study Looking at How Well Semaglutide Works in People Living With Obesity and PrediabetesCompletedNCT05040971Phase 3Results posted
• Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in People Who Are Overweight or Living With Obesity (OASIS 1)CompletedNCT05035095Phase 3Results posted
• A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE)CompletedNCT05035082Phase 4Results posted
• Research Study Investigating How Well Semaglutide Works in People From Thailand and South Korea Living With ObesityCompletedNCT04998136Phase 3Results posted
• Research Study to Look at How Well Cagrilintide Together With Semaglutide Works in People With Type 2 DiabetesCompletedNCT04982575Phase 2Results posted
• Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)CompletedNCT04971785Phase 2Results posted
• A Research Study to Investigate How Well NNC0165-1875 in Combination With Semaglutide Works in People With ObesityCompletedNCT04969939Phase 2Results posted
• A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (the REMODEL Trial)CompletedNCT04865770Phase 3Results posted
• Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and ObesityCompletedNCT04788511Phase 3Results posted
• GLP-1 Analogue Effects on Food Cues, Stress, Motivation for Highly Palatable Foods, and WeightCompletedNCT04779697Phase 1Results posted
• Effect of Subcutaneous Semaglutide on Kidney Transplant CandidacyTerminatedNCT04741074Phase 3Results posted
• Research Study to Compare Three Doses of Semaglutide Tablets Taken Once Daily in People With Type 2 DiabetesCompletedNCT04707469Phase 3Results posted
• Treatment of GLP-1 for Diabetic Bariatric PatientsTerminatedNCT04624672Phase 4Results posted
• A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 DiabetesCompletedNCT04596631Phase 3Results posted
• A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 DiabetesCompletedNCT04560998Phase 3Results posted
• Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With T2DCompletedNCT04538352Phase 4Results posted
• Research Study of How Well Semaglutide Works in People Living With Overweight or Obesity.CompletedNCT04251156Phase 3Results posted
• Study of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome With Insulin Resistance, Increased Hepatic Lipids, and Increased Cardiovascular Disease Risk (The SLIM LIVER Study)CompletedNCT04216589Phase 2Results posted
• Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide scCompletedNCT04189848Phase 4Results posted
• A Study Comparing the Injection Site Pain Experience After the Injection of Semaglutide B and Semaglutide D With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and ObesityCompletedNCT04143945Phase 2Results posted
• Impact of Semaglutide on CD34+ EPC and Fat Derived MSCCompletedNCT04126603Phase 4Results posted
• A Research Study Comparing a New Medicine Oral Semaglutide to Placebo in People With Type 2 DiabetesCompletedNCT04109547Phase 3Results posted
• A Research Study on How Well Semaglutide Works in Adolescents With Overweight or ObesityCompletedNCT04102189Phase 3Results posted
• Research Study to Investigate How Well Semaglutide Works Compared to Liraglutide in People Living With Overweight or ObesityCompletedNCT04074161Phase 3Results posted

← Semaglutide overview